SAN DIEGO, May 22, 2017 /PRNewswire/ -- NuVasive, Inc.
(NASDAQ: NUVA), a leading medical device company focused on
transforming spine surgery with minimally disruptive,
procedurally-integrated solutions, today announced the Company's
increased investment and support of adult and pediatric deformity
research, education, and awareness initiatives throughout 2017.
NuVasive increased its focus on the $2.5
billion deformity market in May
2015 with the launch of its Integrated Global Alignment®
(iGA®) platform and RELINE® posterior fixation system. In
February 2016, NuVasive expanded its
footprint into the early onset scoliosis market with the addition
of its industry-leading MAGEC® system, which utilizes innovative
magnetic technology within adjustable growing rods. Today, NuVasive
has the fastest growing spinal deformity portfolio and is expanding
its support of key programs to drive improved clinical and economic
outcomes. NuVasive recently launched the 'Embracing the Journey
Together' program, which includes pediatric spinal deformity
research, education and spinal deformity event support, supporting
leading surgeons as they educate surgeons around the world.
"At NuVasive, we remain laser-focused on transforming the lives
of patients through disruptive innovation and support of clinical
education and research," said Greg
Lucier, NuVasive chairman and chief executive officer.
"We've made tremendous gains in adult and pediatric spinal
deformity innovation, with the versatile RELINE portfolio and MAGEC
system. With the upcoming launch of the RELINE Small Stature system
available this summer, I'm confident in our ability to outpace the
market. We're proud NuVasive has taken the lead in supporting key
global initiatives designed to help improve the lives of patients
around the world."
Part of the Company's investment into pediatric spinal deformity
care includes funding research and patient initiatives, such as the
Harms Study Group and its Setting Scoliosis Straight Foundation, as
the exclusive sponsor of the Power Over Scoliosis event. NuVasive
is also providing research funding for the Children's Spine Study
Group and the Growing Spine Study Group.
NuVasive was a key sponsor of EPOSNA 2017, the combined meeting
of EPOS and POSNA, held earlier this month in Barcelona, Spain. In July, NuVasive is the
leading sponsor of IMAST 2017, the International Meeting on
Advanced Spine Techniques hosted by the Scoliosis Research Society.
The Company is also the leading sponsor of ICEOS, the International
Congress of Early-onset Scoliosis, in November.
The Company also announced the launch of a monthly podcast
series, MAGEC Matters, featuring interviews with leading
surgeons in pediatric deformity discussing tips for the treatment
of early onset scoliosis, which is now available on iTunes,
SoundCloud and other leading podcast platforms.
Other events supported by NuVasive throughout 2017 include:
- Setting Scoliosis Straight: Patient & Family Power over
Scoliosis Educational Event
June 2-3, 2017; Miami
- Shriners Hospital for Children – Chicago "Early Onset Scoliosis
and Management Strategies" Meeting
June 9, 2017; Chicago
- International Meeting on Advanced Spine Techniques (IMAST)
July 12-15, 2017; Cape Town, South Africa
- Scoliosis Research Society (SRS)
Sept. 6-9, 2017; Philadelphia
- Pediatric Orthopedic Surgical Techniques Lab (POST)
Sept. 29-30, 2017; Memphis, Tenn.
- International Congress of Early-onset Scoliosis (ICEOS)
Nov. 16-17; 2017, San Diego
- 2017 MAGEC Users Meeting
Nov. 17-18, 2017; San Diego
- International Pediatric Orthopaedic Symposium (IPOS)
Nov. 28-Dec 2, 2017; Orlando, Fla.
- Spina Bifida Association Walk-n-Roll Events
Various U.S. cities throughout 2017
About NuVasive
NuVasive,
Inc. (NASDAQ: NUVA) is a world leader in minimally invasive,
procedurally-integrated spine solutions. From complex spinal
deformity to degenerative spinal conditions, NuVasive is
transforming spine surgery with innovative technologies designed to
deliver reproducible and clinically proven surgical outcomes.
NuVasive's highly differentiated, procedurally-integrated solutions
include access instruments, implantable hardware and software
systems for surgical planning and reconciliation technology that
centers on achieving the global alignment of the spine. With
$962 million in revenues (2016),
NuVasive has an approximate 2,300 person workforce in more than 40
countries around the world. For more information, please visit
www.nuvasive.com.
Forward-Looking
Statements
NuVasive cautions you that
statements included in this news release that are not a description
of historical facts are forward-looking statements that involve
risks, uncertainties, assumptions and other factors which, if they
do not materialize or prove correct, could
cause NuVasive's results to differ
materially from historical results or those expressed or implied by
such forward-looking statements. The potential risks and
uncertainties which contribute to the uncertain nature of these
statements include, among others, risks associated with acceptance
of the Company's surgical products and procedures by spine
surgeons, development and acceptance of new products or product
enhancements, clinical and statistical verification of the benefits
achieved via the use of NuVasive's products (including
the iGA®platform), the Company's ability to effectually
manage inventory as it continues to release new products, its
ability to recruit and retain management and key personnel, and the
other risks and uncertainties described
in NuVasive's news releases and periodic
filings with the Securities and Exchange
Commission. NuVasive's public filings with
the Securities and Exchange Commission are
available
at www.sec.gov. NuVasive assumes
no obligation to update any forward-looking statement to reflect
events or circumstances arising after the date on which it was
made.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/nuvasive-announces-educational-initiatives-in-support-of-spines-fastest-growing-spinal-deformity-portfolio-300461217.html
SOURCE NuVasive, Inc.